Sanofi Takes Sun To Court Over Generic Eloxatin
By Erin Coe ( June 21, 2011, 4:25 PM EDT) -- Sanofi-Aventis SA filed a suit Friday in New Jersey seeking to block Sun Pharmaceutical Industries Ltd. from launching a generic version of the French drugmaker's colorectal cancer treatment Eloxatin before August 2012 as provided under a license agreement between the parties....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.